RLS Global AB (publ)
RLS Global AB (publ)
Share · SE0005190725 (XSTO)
Overview
No Price
n/a
Share Float & Liquidity
Free Float -
Shares Float -
Shares Outstanding 80,05 M
Company Profile for RLS Global AB (publ) Share
RLS Global AB (publ), a medical technology company, develops and sells products for the treatment of illnesses in wound and oral care in Sweden. Its products include ChloraSolv that is used for the treatment of chronic diabetic foot and leg ulcers for diabetic patients; and CariSolv, a gel used for removing caries. The company was founded in 1996 and is based in Mölndal, Sweden.
Get up to date insights from finAgent about RLS Global AB (publ)

Company Data

Name RLS Global AB (publ)
Company RLS Global AB (publ)
Website https://rls.global
Primary Exchange XSTO NASDAQ STOCKHOLM AB
ISIN SE0005190725
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Roland Frosing
Market Capitalization 36 Mio
Country Sweden
Currency SEK
Employees 0,0 T
Address Neongatan 5, 431 53 Mölndal
IPO Date 2005-07-11

Ticker Symbols

Name Symbol
NASDAQ STOCKHOLM AB RLS.ST
More Shares
Investors who hold RLS Global AB (publ) also have the following shares in their portfolio:
Eliem Therapeutics, Inc - Common Stock
Eliem Therapeutics, Inc - Common Stock Share
PT Kimia Farma (Persero) Tbk
PT Kimia Farma (Persero) Tbk Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025